Sutrilneo Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Torasemide

Indications/Uses

Essential HTN; oedema due to CHF, kidney or liver disease.

Click to view Sutrilneo detailed prescribing information

Dosage/Direction for Use

Adult HTN Initially 5 mg once daily, may be increased to 10 mg once daily, or combine w/ additional antihypertensive agent. Oedema associated w/ CHF, renal or hepatic disease Initially 5-20 mg once daily, may be increased to approx double the dose.

Click to view Sutrilneo detailed prescribing information

Overdosage

View Sutrilneo overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Take sufficient quantity of liqd. Swallow whole, do not crush/chew.

Contraindications

Hypersensitivity to torasemide, or other sulphonylureas. Anuria.

Click to view Sutrilneo detailed prescribing information

Special Precautions

Serious hepatic disease; coma state may be precipitated; low blood Na or K levels, low blood vol; heart diseases, increased risk of cardiac arrhythmias in concurrent treatment w/ cardiac glycosides; gout or diabetes; renal failure or urinary problems; hypotension. Contains lactose; patients w/ lactose intolerance. May impair ability to drive or operate machinery if taken w/ alcohol. Not recommended in childn. Not recommended during pregnancy & lactation.

Click to view Sutrilneo detailed prescribing information

Use In Pregnancy & Lactation

Click to view Sutrilneo detailed prescribing information

Adverse Reactions

Dizziness, headache, drowsiness; diarrhoea; increased urinary frequency, urine vol, night time urine productions.

Drug Interactions

Increased effect of cardiac glycosides, eg, digoxin. Increased ear toxicity w/ aminoglycosides & ethacrynic acid. Increased toxicity of lithium & salicylates. Decreased effect w/ NSAIDs (eg, ibuprofen, indomethacin), probenecid & cholestyramine.

Click to view Sutrilneo detailed prescribing information

Storage

View Sutrilneo storage conditions for details to ensure optimal shelf-life.

Description

View Sutrilneo description for details of the chemical structure and excipients (inactive components).

Action

View Sutrilneo mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Diuretics

ATC Classification

C03CA04 - torasemide ; Belongs to the class of high-ceiling sulfonamide diuretics.

Regulatory Classification

POM

Presentation/Packing

Form

Sutrilneo PR tab 10 mg

Packing/Price

15's;30's

Form

Sutrilneo PR tab 5 mg

Packing/Price

15's;30's

Sutrilneo

torasemide

Manufacturer:

Ferrer Internacional

Distributor:

Maxxcare

Marketer:

Mega Lifesciences